Management Will Highlight Its Recently Announced Acquisition of the Laserscope Aesthetics Business
MOUNTAIN VIEW, Dec. 5 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has been invited to present at the BMO Capital Markets Focus on Healthcare Conference, which will take place at the Millennium Broadway Hotel in New York City. The Company will discuss its recently announced acquisition of the Laserscope aesthetics business, its business strategy and the Company's overall performance on Thursday, December 7, 2006 at 11:00 a.m. Eastern Time. The presentation will be made by IRIDEX President and CEO, Barry G. Caldwell.
Attendance at the conference is by invitation only. IRIDEX will offer a live audio webcast of its presentation, which may be accessed at the Company's website at www.iridex.com. An archived replay of the presentation will be available 48 hours following the live presentation and will also be available at www.iridex.com.
About IRIDEX
IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin diseases in dermatology markets (also referred to as aesthetics). IRIDEX products are sold in the United States through a direct sales force and internationally through a network of 77 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com .
SOURCE IRIDEX Corporation
12/05/2006
CONTACT: Larry Tannenbaum, Chief Financial Officer of IRIDEX
Corporation, +1-650-940-4700
Web site: http://www.iridex.com
(IRIX)
